Sun Pharmaceutical Faces Mixed Trends Amid Broader Market Performance Challenges
Sun Pharmaceutical Industries has seen a decline in stock performance after a three-day gain streak, trading at Rs 1640.65. The stock's moving averages indicate a mixed short-term trend. With a market cap of Rs 3,97,498.00 crore, it has experienced an 8.46% decline over the past year.
Sun Pharmaceutical Industries has experienced notable activity today, reflecting a performance that underperformed the sector by 0.69%. After a three-day streak of gains, the stock has seen a decline, trading consistently at Rs 1640.65 since the market opened. In terms of moving averages, the stock is currently positioned higher than its 5-day moving average but lower than the 20-day, 50-day, 100-day, and 200-day moving averages, indicating a mixed short-term trend.
With a market capitalization of Rs 3,97,498.00 crore, Sun Pharmaceutical operates within the Pharmaceuticals & Biotechnology industry, where the average price-to-earnings (P/E) ratio stands at 35.75, slightly above Sun's P/E of 34.66.
Over the past year, the stock has declined by 8.46%, contrasting with the Sensex's modest drop of 0.54%. In the broader context, the stock's year-to-date performance shows a significant decrease of 13.92%, while its three-year and five-year performances remain robust at 84.44% and 209.02%, respectively, compared to the Sensex's 38.11% and 107.95%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
